Home › Long COVID › Illinois
Long COVID clinical trials in Illinois
14 studies for Long COVID are looking for participants at sites in Illinois.
Cities in Illinois
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of Age
- Eagle Clinical Research, LLC, Chicago
RecruitingPhase 2Healthy volunteers welcome
6 Months – 11 Years · All sexes · Updated Nov 9, 2026 · NCT07808697A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- Rush University Medical Center ( Site 3748), Chicago
- Duly Health and Care ( Site 3799), Lombard
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT06667700Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- University of Illinois Health, Chicago
RecruitingPhase 3
28 Days · All sexes · Updated Nov 4, 2026 · NCT02735707Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Evanston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT05624450A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Endeavor Health Evanston Hospital, Evanston
- Koch Family Medicine, Morton
- Endeavor Health Clinical Trials Center, Skokie
- and 1 more
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Oct 15, 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Northwestern Memorial Hospital, Chicago
- Northwestern University Feinberg School of Medicine, Chicago
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT07013474Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
- Illinois Research Network (ILLInet), University of Illinois Chicago, Chicago
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06631287Dime La VerDAD: Verify, Debunk, and Disseminate
- University of Chicago, Chicago
RecruitingHealthy volunteers welcome
Ages 18 to 99 · All sexes · Updated Aug 26, 2026 · NCT06417762Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RecruitingPhase 3
All ages · All sexes · Updated Jun 23, 2026 · NCT03808922Cognitive-Sensorimotor Function in Long-COVID
- Jesse Brown VA Medical Center, Chicago, IL, Chicago
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT06850350Dysbiosis & Long COVID
- The University of Chicago, Chicago
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 80 · All sexes · Updated Mar 2, 2026 · NCT06825819A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection
- University of Chicago, Chicago
RecruitingPhase 4Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Nov 10, 2025 · NCT06008860EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
- University of Chicago Medical Center, Chicago
RecruitingPhase 3
Ages 0 to 17 · All sexes · Updated Jul 17, 2025 · NCT05261139Convalescent Plasma as a Possible Treatment for COVID-19
- University of Illinois at Chicago, Chicago
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Jun 22, 2020 · NCT04442191From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.